155 related articles for article (PubMed ID: 31053147)
1. Hematopoietic stem cell transplantation in a patient with type 1 mosaic variegated aneuploidy syndrome.
Laberko A; Balashov D; Deripapa E; Soldatkina O; Raikina E; Maschan A; Novichkova G; Shcherbina A
Orphanet J Rare Dis; 2019 May; 14(1):97. PubMed ID: 31053147
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic correlation between mosaic variegated aneuploidy 1 (MVA1) and a novel BUB1B variant: a reappraisal of a severe syndrome.
Pavone P; Pappalardo XG; Mustafa N; Falsaperla R; Marino SD; Corsello G; Bianca S; Parano E; Ruggieri M
Neurol Sci; 2022 Nov; 43(11):6529-6538. PubMed ID: 35804254
[TBL] [Abstract][Full Text] [Related]
3. A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ
Balashov D; Laberko A; Shcherbina A; Trakhtman P; Abramov D; Gutovskaya E; Kozlovskaya S; Shelikhova L; Novichkova G; Maschan M; Rumiantsev A; Maschan A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1432-1440. PubMed ID: 29550630
[TBL] [Abstract][Full Text] [Related]
4. Treosulfan-Based Conditioning Regimen in Haematopoietic Stem Cell Transplantation with TCRαβ/CD19 Depletion in Nijmegen Breakage Syndrome.
Laberko A; Sultanova E; Gutovskaya E; Radygina S; Deripapa E; Kantulaeva A; Trakhtman P; Brilliantova V; Starichkova J; Shcherbina A; Maschan M; Maschan A; Balashov D
J Clin Immunol; 2020 Aug; 40(6):861-871. PubMed ID: 32602054
[TBL] [Abstract][Full Text] [Related]
5. CD3
Ramanathan S; Lum SH; Nademi Z; Carruthers K; Watson H; Flood T; Owens S; Williams E; Hambleton S; Gennery AR; Slatter M
Transplant Cell Ther; 2023 Aug; 29(8):513.e1-513.e9. PubMed ID: 37279857
[TBL] [Abstract][Full Text] [Related]
6. Post-Transplantation Immunosuppression After TCRΑβ/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency.
Laberko A; Idarmacheva A; Glushkova S; Pershin D; Shelikhova L; Maschan M; Maschan A; Balashov D
Transplant Cell Ther; 2022 Mar; 28(3):172.e1-172.e4. PubMed ID: 34875404
[TBL] [Abstract][Full Text] [Related]
7. Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies.
Laberko A; Sultanova E; Gutovskaya E; Shipitsina I; Shelikhova L; Kurnikova E; Muzalevskii Y; Kazachenok A; Pershin D; Voronin K; Shcherbina A; Maschan M; Maschan A; Balashov D
Blood; 2019 Nov; 134(20):1755-1763. PubMed ID: 31558465
[TBL] [Abstract][Full Text] [Related]
8. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
[TBL] [Abstract][Full Text] [Related]
9. Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome.
Schwinger W; Sovinz P; Benesch M; Lackner H; Seidel M; Strenger V; Sperl D; Raicht A; Brunner-Krainz M; Paschke E; Plecko B; Urban C
Pediatr Hematol Oncol; 2014 Nov; 31(8):723-30. PubMed ID: 25116402
[TBL] [Abstract][Full Text] [Related]
10. BCG-Related Inflammatory Syndromes in Severe Combined Immunodeficiency After TCRαβ+/CD19+ Depleted HSCT.
Laberko A; Yukhacheva D; Rodina Y; Abramov D; Konovalov D; Radygina S; Shelikhova L; Pershin D; Kadnikova O; Maschan M; Maschan A; Balashov D; Shcherbina A
J Clin Immunol; 2020 May; 40(4):625-636. PubMed ID: 32377975
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic heterogeneity in patients with mosaic variegated aneuploidy: delineation of clinical subtypes.
García-Castillo H; Vásquez-Velásquez AI; Rivera H; Barros-Núñez P
Am J Med Genet A; 2008 Jul; 146A(13):1687-95. PubMed ID: 18548531
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome.
Hanks S; Coleman K; Summersgill B; Messahel B; Williamson D; Pritchard-Jones K; Strefford J; Swansbury J; Plaja A; Shipley J; Rahman N
Cancer Lett; 2006 Aug; 239(2):234-8. PubMed ID: 16182441
[TBL] [Abstract][Full Text] [Related]
13. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F
Front Immunol; 2020; 11():699. PubMed ID: 32477328
[TBL] [Abstract][Full Text] [Related]
14. TCR α
Mitchell R; Cole T; Shaw PJ; Mechinaud F; O'Brien T; Fraser C
Pediatr Transplant; 2019 Sep; 23(6):e13517. PubMed ID: 31271477
[TBL] [Abstract][Full Text] [Related]
15. Donor-derived CAR-T Cells Serve as a Reduced-intensity Conditioning Regimen for Haploidentical Stem Cell Transplantation in Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Case Report and Review of the Literature.
Zhang C; Kong PY; Li S; Chen T; Ni X; Li Y; Wang M; Liu Y; Gao L; Gao L; Peng XG; Sun AH; Wang P; Yang Z; Zhang X; Qian C
J Immunother; 2018; 41(6):306-311. PubMed ID: 29864079
[TBL] [Abstract][Full Text] [Related]
16. T-cell receptor αβ
Shah RM; Elfeky R; Nademi Z; Qasim W; Amrolia P; Chiesa R; Rao K; Lucchini G; Silva JMF; Worth A; Barge D; Ryan D; Conn J; Cant AJ; Skinner R; Abd Hamid IJ; Flood T; Abinun M; Hambleton S; Gennery AR; Veys P; Slatter M
J Allergy Clin Immunol; 2018 Apr; 141(4):1417-1426.e1. PubMed ID: 28780238
[TBL] [Abstract][Full Text] [Related]
17. Nearly complete deletion of BubR1 causes microcephaly through shortened mitosis and massive cell death.
Simmons AJ; Park R; Sterling NA; Jang MH; van Deursen JMA; Yen TJ; Cho SH; Kim S
Hum Mol Genet; 2019 Jun; 28(11):1822-1836. PubMed ID: 30668728
[TBL] [Abstract][Full Text] [Related]
18. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
[TBL] [Abstract][Full Text] [Related]
19. Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia.
Leahy AB; Li Y; Talano JA; Elgarten CW; Seif AE; Wang Y; Johnson B; Monos DS; Kadauke S; Olson TS; Freedman J; Wray L; Grupp SA; Bunin N
Blood Adv; 2022 Feb; 6(4):1175-1185. PubMed ID: 34872106
[TBL] [Abstract][Full Text] [Related]
20. Generation and flow cytometric quality control of clinical-scale TCRαβ/CD19-depleted grafts.
Bremm M; Cappel C; Erben S; Jarisch A; Schumm M; Arendt A; Bonig H; Klingebiel T; Koehl U; Bader P; Huenecke S
Cytometry B Clin Cytom; 2017 Mar; 92(2):126-135. PubMed ID: 26416332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
